Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-21 Leverone Jason A. Chief Financial Officer Sale −302 $2.97 $898 18,500
2026-09-21 Saccomano Nicholas A President and CEO Sale −87 $2.97 $259 11,160
2026-08-07 Hartley Dylan Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Hartley Dylan Chief Scientific Officer Returned to the company · Employee Stock Option (right to buy) −137,603 0
2026-08-07 Hartley Dylan Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +137,603 137,603
2026-08-07 Phillips Andrew John Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-08-07 Jansen Valerie Malyvanh Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-08-07 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Agresta Samuel Chief Medical Officer Returned to the company · Employee Stock Option (right to buy) −18,588 0
2026-08-07 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +18,588 18,588
2026-08-07 Agresta Samuel Chief Medical Officer Returned to the company · Employee Stock Option (right to buy) −131,396 0
2026-08-07 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +131,396 131,396
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy −5,781 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy +5,781 5,781
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −5,322 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +5,322 5,322
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −130,611 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +130,611 130,611
2026-08-07 Carruthers R Michael Director Grant or award · Stock Option (right to buy) +22,350 22,350

Page 1 of 8 · 154 trades